Amid debates about proposed cuts to federal Medicaid spending, this brief analyzes key characteristics of children with special health care needs and explores how Medicaid provides them with coverage.
The insurance giant and Optum parent is forecasting a 2025 medical care ratio roughly a point above last year’s 85.5 percent.
The American Medical Association released a new report on Monday on pharmacy benefit managers. It explained that there is low competition among PBMs and high vertical integration with payers. The post AMA Report Details Low Competition in PBM Market appeared first on MedCity News.
Time’s almost up to get health coverage for 2025. Act before January 15 to enroll in health coverage that starts February 1. Image Enroll in health coverage now that meets your budget & needs Depending on your expected household income for the year, you or members of your household may qualify for lower costs or…
Phase 2 data for Cargo Therapeutics’ CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events. Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025. The post…
One day after the murder of UnitedHealthcare’s CEO, police are searching for the shooter
This fact sheet provides an overview of health coverage for immigrants based on data from the 2023 KFF/LA Times Survey of Immigrants, the largest nationally representative survey focused on immigrants and discusses potential implications of incoming Trump administration policies for coverage of immigrants.
The PTC Therapeutics gene therapy, Kebilidi, treats an enzyme deficiency that affects the body’s ability to produce dopamine, a neurotransmitter important for motor control. FDA approval for the product comes two years after it won its first regulatory approvals in Europe. The post PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly…
The Common Health Coalition’s Challenge on Community Health Workers is designed to advance meaningful CHW initiatives through partnerships between healthcare and public health
Labcorp’s latest acquisition brings the oncology testing business of BioReference Health. Opko Health, BioReference’s parent, has been cutting costs to return to profitability. The post Labcorp Is Buying BioReference Health’s Cancer Testing Business for $192M appeared first on MedCity News.